Large-Cap Index Performance Overview

The BSE 100 index, a benchmark for large-cap stocks, has shown signs of weakness in the current trading week. The index’s decline of 1.16% on 13 Feb 2026 marks a continuation of a downward trend that has seen a 1.37% drop over the last five trading days. This performance contrasts with the broader market’s mixed signals, where mid and small caps have exhibited varying degrees of volatility.

Market breadth within the large-cap universe remains subdued, with only 10 stocks advancing against 90 decliners, resulting in an advance-decline ratio of 0.11x. This lopsided distribution underscores the selective nature of buying interest, concentrated in a handful of resilient names while the majority face selling pressure.

Heavyweight Movers and Technical Upgrades

Among the large-cap constituents, several heavyweight stocks have recently undergone technical rating upgrades, signalling potential shifts in investor sentiment. Larsen & Toubro (L&T), UltraTech Cement, Tech Mahindra, and Sun Pharmaceutical Industries have all been upgraded from Hold to Buy ratings, reflecting improved technical momentum and positive outlooks.

L&T’s technical stance has evolved from mildly bullish to bullish, indicating strengthening price action and potential for further gains. Similarly, AU Small Finance Bank, ONGC, and Samvardhana Motherson have seen their technical calls improve from mildly bullish to bullish, suggesting a broadening base of stocks with positive momentum within the large-cap space. Conversely, Tech Mahindra’s rating has moderated slightly from bullish to mildly bullish, signalling a more cautious near-term outlook despite its upgrade to a Buy rating.

Performance Extremes: Best and Worst Large-Cap Stocks

Within the large-cap segment, Apollo Hospitals has emerged as the best performer, delivering a modest return of 0.50% amid the broader market weakness. The healthcare sector’s defensive qualities have likely contributed to Apollo’s relative resilience, as investors seek stability amid uncertain economic conditions.

On the other hand, Infosys has been the worst performer in the large-cap universe, plunging 6.41%. The sharp decline in Infosys shares reflects concerns over IT sector headwinds, including margin pressures and subdued deal pipelines, which have weighed heavily on investor confidence in the technology space.

Defensive Versus Cyclical Trends in Large Caps

The current market environment has highlighted a divergence between defensive and cyclical stocks within the large-cap segment. Defensive sectors such as healthcare and select consumer staples have demonstrated relative strength, as exemplified by Apollo Hospitals’ positive returns. Investors appear to be favouring companies with stable earnings and resilient business models amid concerns over global economic growth and inflationary pressures.

Conversely, cyclical sectors, including technology and industrials, have faced headwinds. Infosys’s steep decline is emblematic of the challenges confronting the IT sector, where demand softness and margin compression have dampened sentiment. Similarly, despite technical upgrades, stocks like Larsen & Toubro and UltraTech Cement have struggled to sustain upward momentum, reflecting broader caution around infrastructure and construction activity.

Technical and Fundamental Outlook

The recent technical upgrades in several large-cap stocks suggest that certain pockets of the market are positioning for a recovery or at least a stabilisation. The shift from Hold to Buy ratings for L&T, UltraTech Cement, Tech Mahindra, and Sun Pharma indicates improving price action and potential entry points for investors seeking quality large-cap exposure.

However, the overall negative breadth and the sizeable number of decliners caution against broad-based optimism. The large-cap index’s decline over the past week and the dominance of losers highlight persistent selling pressure. Investors should remain vigilant, balancing exposure between defensive names that offer stability and cyclical stocks that may provide upside on a recovery but carry higher risk.

Market Sentiment and Investor Implications

Investor sentiment in the large-cap space remains cautious, with a clear preference for quality and defensive characteristics. The technical upgrades provide some encouragement, signalling that select stocks are gaining favour and may lead a turnaround. Yet, the pronounced underperformance of key IT stocks and the subdued advance-decline ratio suggest that broad market participation is lacking.

For portfolio construction, this environment favours a selective approach. Investors might consider overweighting defensive large caps with stable earnings and strong balance sheets while maintaining a measured exposure to cyclical names that have demonstrated technical improvement but remain vulnerable to macroeconomic shifts.

Conclusion: Navigating the Large-Cap Landscape

The large-cap segment is currently navigating a challenging phase marked by a modest but persistent decline in the BSE 100 index. While technical upgrades in key stocks such as Larsen & Toubro, UltraTech Cement, Tech Mahindra, and Sun Pharma offer glimmers of hope, the overall market breadth and performance metrics suggest caution.

Defensive sectors continue to outperform cyclical counterparts, reflecting investor preference for stability amid uncertain economic conditions. The sharp underperformance of Infosys and other IT stocks highlights sector-specific risks that may persist in the near term.

Investors should adopt a balanced strategy, focusing on quality large caps with strong fundamentals and positive technical signals while remaining mindful of broader market risks. Monitoring technical upgrades and sectoral trends will be crucial in identifying opportunities as the market evolves.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →